Comment from Kelly Paul

Summary: Kelly Paul, a patient living with mycosis fungoides, supports the petition to establish a context-based evidence framework for rare diseases. She argues that standard trial designs are often unsuitable for rare diseases with small populations and that a disease-specific framework would provide more meaningful evidence and investment certainty for patients.